The problem
Women with PCOS, thyroid or hormonal issues get dismissed and bounced between specialists with no joined-up care
What they do
Insurance-covered virtual care for women's hormonal, metabolic and reproductive conditions like PCOS
Traction 120,000+ women served; revenue grew 4x in 2024 (CEO); team +38% YoY
Hiring trend
- Open roles
- 217
- Ops roles
- 4
- Headcount
- ~240
Headcount ~240, team +38% YoY (Dealroom est.); job board 14 → 213 postings Apr → Oct 2026, mostly 1099 clinicians
Hiring in
- New York
- Illinois
- Texas
- Remote (Philippines)
Glassdoor
3.8 ★ 7 reviews ↗Funding
- Last round
- $30M
- Stage
- Series B+ (undisclosed)
- Date
- Oct 2026
Led by Index Ventures, GV
- Hiring+2217 open roles on the live job board (30+ roles = +2)
- Funding recency+1.5Series B+ (undisclosed) · $30M, Oct 2026 (this month): 6 months or less = +1.5
- Traction—120,000+ women served; revenue grew 4x in 2024 (CEO); team +38% YoY
- Red flags—None on file
- Total3.25Stored score → Steady (1.5–3.49)
Hiring and funding from the stored fields add up to +3.5. The stored score of 3.25 includes a judgment call the fields don't capture (often a boundary month or a round we don't count), so traction and red-flag points can't be split out exactly.
Distance (10K) is a separate read on how long the lead can last. It doesn't change the score.
Distance
10K · edge: cheaper at size
Leading specialist in insurance-covered PCOS and hormonal care, with payer contracts in most states and 120,000 women served, but it is now pushing into GLP-1s, perimenopause and urgent care, where Midi and Hims & Hers are far bigger.
Sources: Allara: $30M raise, 120,000+ women served, new GLP-1, perimenopause and urgent care lines (Oct 2026) ↗ · Fierce Healthcare: Allara raises $30M, works with major commercial payers (Oct 2026) ↗
Last checked Oct 25, 2026